Page 8 - நீதி ககன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog: On June 29, 2021, the Supreme Court limited the doctrine of assignor estoppel that has long prevented inventors from challenging the validity of patents they have assigned to a third party.  The judicially-created doctrine is grounded in fairness and prevents a patent assignor from warranting (at least implicitly) to the buyer that the patent is valid, but then later challenging the validity of the patent. In Minerva Surgical, Inc. v. Hologic, Inc. [1], the patent claims a device to treat abnormal uterine bleeding that used a moisture-permeable applicator.  The inventor assigned the patent application for the device to his company, Novacept, Inc., which was later acquired by Hologic, Inc.  The inventor subsequently founded Minerva Surgical, Inc., where he developed and patented a similar device for treating uterine bleeding, but that used a moisture-impermeable applicator.  In the meantime, Hologic filed a continua

Justice kaganBurr formanSupreme courtMinerva surgical incDistrict courtNovacept incHologic incMinerva surgicalFederal circuitநீதி ககன்பர் ஆடவருக்கானஉச்ச நீதிமன்றம்மினெர்வா அறுவை சிகிச்சை இன்க்மாவட்டம் நீதிமன்றம்மினெர்வா அறுவை சிகிச்சைகூட்டாட்சியின் சுற்று